Daiichi Sankyo enrolls first patient in Nimotuzumab Phase 3 clinical trials
25 April 2013 | By Daiichi Sankyo
The first patient has been enrolled in two pivotal phase 3 clinical trials of nimotuzumab...
List view / Grid view
25 April 2013 | By Daiichi Sankyo
The first patient has been enrolled in two pivotal phase 3 clinical trials of nimotuzumab...
25 April 2013 | By Sanofi
Genzyme announced positive top-line results from the TOPIC trial for AUBAGIO...
25 April 2013 | By Sanofi
More than 200 million treatments of ASAQ Winthrop have been distributed in Africa...
25 April 2013 | By Novartis
"We believe that this innovative campaign will help speed malaria elimination..."
25 April 2013 | By Pfizer
Pfizer intends to appeal and seek re-examination...
25 April 2013 | By Gerresheimer
Requirements of innovative packaging products are getting increasingly stringent...
24 April 2013 | By Burson-Marsteller
Janssen has submitted a MAA to the EMA seeking approval for simeprevir...
24 April 2013 | By Sanofi Pasteur
Company also expands injectable polio vaccine production capacity...
24 April 2013 | By Novartis
Novartis announced the compensation for the incoming Chairman of the Board, starting August 1, 2013...
24 April 2013 | By Boehringer Ingelheim
Net sales rose by 11.5 percent to around €14.7 billion...
23 April 2013 | By Merck
Merck announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial...
23 April 2013 | By TEVA
"We are very pleased to receive orphan drug designation for XEN402..."
23 April 2013 | By Gilead Sciences
Detailed results from four Phase 3 clinical trials...
23 April 2013 | By Alchemia Limited
Alchemia has signed a multi-target, drug discovery collaboration with AstraZeneca...
23 April 2013 | By Boehringer Ingelheim
Results from the pivotal Phase III STARTVerso™1 trial...